Literature DB >> 24667572

Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.

Vivek K Pawar1, Yuvraj Singh1, Jaya Gopal Meher1, Siddharth Gupta1, Manish K Chourasia2.   

Abstract

Formulation of nanocrystals is a robust approach which can improve delivery of poorly water soluble drugs, a challenge pharmaceutical industry has been facing since long. Large scale production of nanocrystals is done by techniques like precipitation, media milling and, high pressure homogenization. Application of appropriate stabilizers along with drying accords long term stability and commercial viability to nanocrystals. These can be administered through oral, parenteral, pulmonary, dermal and ocular routes showing their high therapeutic applicability. They serve to target drug molecules in specific regions through size manipulation and surface modification. This review dwells upon the in-vivo fate and varying applications in addition to the facets of drug nanocrystals stated above.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioavailability; In-vivo fate; Nanocrystals; Poorly soluble drugs; Stability; Targeted delivery

Mesh:

Substances:

Year:  2014        PMID: 24667572     DOI: 10.1016/j.jconrel.2014.03.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  45 in total

Review 1.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

2.  Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.

Authors:  Sandeep K Singh; Vishal Makadia; Shweta Sharma; Mamunur Rashid; Sudhir Shahi; Prabhat R Mishra; Mohammed Wahajuddin; Jiaur R Gayen
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

3.  Long Acting Ionically Paired Embonate Based Nanocrystals of Donepezil for the Treatment of Alzheimer's Disease: a Proof of Concept Study.

Authors:  Naresh Mittapelly; Maharshi Thalla; Gitu Pandey; Venkatesh Teja Banala; Shweta Sharma; Abhishek Arya; Sandeep Mishra; Kalyan Mitra; Shubha Shukla; Prabhat Ranjan Mishra
Journal:  Pharm Res       Date:  2017-08-14       Impact factor: 4.200

Review 4.  Application of UV Imaging in Formulation Development.

Authors:  Yu Sun; Jesper Østergaard
Journal:  Pharm Res       Date:  2016-10-20       Impact factor: 4.200

Review 5.  Nanocrystal for ocular drug delivery: hope or hype.

Authors:  Om Prakash Sharma; Viral Patel; Tejal Mehta
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 6.  Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.

Authors:  Zonghua Tian; Yaping Mai; Tingting Meng; Shijie Ma; Guojing Gou; Jianhong Yang
Journal:  AAPS PharmSciTech       Date:  2021-06-14       Impact factor: 3.246

Review 7.  Development Considerations for Nanocrystal Drug Products.

Authors:  Mei-Ling Chen; Mathew John; Sau L Lee; Katherine M Tyner
Journal:  AAPS J       Date:  2017-03-09       Impact factor: 4.009

Review 8.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

9.  Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.

Authors:  Yaya Lei; Yindi Kong; Hong Sui; Jun Feng; Rongyue Zhu; Wenping Wang
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

10.  Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design.

Authors:  Jifu Hao; Yun Gao; Jing Zhao; Jimei Zhang; Qiankui Li; Zhongxi Zhao; Jiyong Liu
Journal:  AAPS PharmSciTech       Date:  2014-09-11       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.